Inducción de la ovulación
Moving from OI to IVF signs it is time?
Letrozole Success Rates with PCOS: What to Expect at Each Dose
August 29, 2026
Letrozole achieves an ovulation rate of 70 to 85% and a cumulative live birth rate of approximately 27.5% per treatment course for women with PCOS, compared to 19.1% with clomiphene. Per-cycle pregnancy rates range from 15 to 27%, and cumulative conception rates across multiple cycles reach 45 to 50% (a figure derived from multi-cycle clinical data rather than a single RCT result). For women who don’t respond to the standard 2.5mg starting dose, sequential escalation to 5mg, 7.5mg, or 10mg is the established clinical next step.
Not sure if letrozole is the right starting point for you? Start with a PCOS fertility assessment →
Understanding PCOS and Letrozole Treatment
PCOS (polycystic ovary syndrome) is the most common hormonal cause of anovulatory infertility, and letrozole, sold under the brand name Femara, is the current first-line treatment for ovulation induction in women with this condition. PCOS affects 1 in 8 women of reproductive age more than 170 million people worldwide making it one of the most frequently encountered causes of difficulty conceiving. In May 2026, an international consensus published in The Lancet formally renamed PCOS to polyendocrine metabolic ovarian syndrome (PMOS); the condition, its diagnosis, and its treatment protocols remain unchanged. (Teede et al., The Lancet, May 2026; doi: 10.1016/S0140-6736(26)00717-8) Whether you’re trying to build your family as a single parent by choice, as a couple, or as an LGBTQ+ patient, PCOS disrupts the hormonal signaling that drives ovulation, and letrozole is designed to address that specific mechanism.
Unlike Clomid (clomiphene citrate), letrozole doesn’t carry anti-estrogenic effects on the endometrium. This matters because it means the uterine lining remains hospitable for implantation even at higher doses. The distinction in success rates is meaningful: according to Legro et al. (2014), letrozole produced significantly higher ovulation and live birth rates compared to clomiphene in women with PCOS, establishing it as the preferred first-line agent.
Take charge of your fertility with experts.
Your body is one of a kind, and so is your treatment. Rely on a highly specialized medical team that explains your options with full transparency, backing every decision with precision technology and genuine, human support from day one.
It’s worth understanding both key success figures, because they measure different things. The 27.5% live birth rate per treatment course reflects a single round of treatment. The 45 to 50% cumulative live birth rate reflects what patients can realistically expect across several cycles. These numbers are not interchangeable, and knowing the difference shapes how to think about how long to continue treatment before reassessing.
If you haven’t been tested yet, fertility testing for PCOS is the right starting point before your first letrozole cycle.
Is Letrozole Better Than Clomid for PCOS?
Yes. For women with PCOS specifically, letrozole consistently outperforms Clomid on the two outcomes that matter most: ovulation rate and live birth rate. The data from the landmark Legro et al. RCT makes the comparison direct:
The live birth rate difference (27.5% vs. 19.1%) is not marginal. For a patient completing multiple cycles, this gap compounds in a meaningful way. Letrozole also carries a lower multiple pregnancy risk than Clomid, which matters both medically and logistically for patients planning treatment from the US.
What Is the Next Step If Letrozole Doesn’t Work?
If 2.5mg of letrozole doesn’t produce ovulation, the established next step is dose escalation, not switching to a different drug. When standard letrozole doses don’t produce ovulation, the clinical protocol is sequential dose escalation: start at 2.5mg, increase to 5mg, then 7.5mg (the most common ceiling), and in resistant cases 10mg. If ovulation occurs but pregnancy doesn’t follow, adding an hCG trigger shot or combining with IUI are the recommended next steps before considering IVF.
The table below outlines the standard escalation scenarios and what to expect at each level:
These scenarios are common. Not responding to 2.5mg does not mean letrozole won’t work for you. It typically means your ovaries need a stronger FSH stimulus to respond.
How Letrozole Dose Escalation Works
Letrozole works by temporarily suppressing estrogen to stimulate FSH release, but women with PCOS often need higher doses to achieve the same ovulatory response due to elevated baseline androgens or more resistant ovaries. When you take letrozole, it blocks aromatase, the enzyme that converts androgens to estrogens. The resulting drop in estrogen signals the pituitary gland to release more FSH (follicle-stimulating hormone), which stimulates follicle development.
Women with PCOS often have higher circulating androgens, which makes the aromatase pathway more active and the estrogen suppression effect proportionally harder to achieve at low doses. This is why the same 2.5mg dose that works for a woman with unexplained anovulation may be insufficient for a patient with classic PCOS and elevated androgen levels.
The dose escalation table below shows cumulative ovulation rates and per-cycle pregnancy rates at each level:
For women who remain resistant even at the maximum 10mg dose with the standard 5-day protocol, emerging evidence supports extended letrozole administration over 10 days. Research published in Fertility and Sterility and F&S Reports has shown improved ovulation rates in a subset of resistant PCOS patients using this approach. An extended protocol is not standard first-line care and requires specialist evaluation to determine whether it applies to your specific situation.
How Many Cycles of Letrozole Does It Take to Get Pregnant?
Most specialists recommend 3 to 4 cycles at each dose level before escalating. Approximately 65 to 70% of women who respond to letrozole conceive within their first three cycles at the effective dose a figure that applies to responders, not to all patients who begin treatment. After six unsuccessful cycles at the maximum tolerated dose, clinical guidelines support reassessing whether IUI or IVF is a more appropriate next step.
This timeline matters for planning. If you complete four cycles at 2.5mg without ovulating, moving to 5mg is standard practice. The six-cycle total threshold before escalating to IVF is recommended by clinical guidelines from the American Society for Reproductive Medicine, not as an arbitrary limit, but because the incremental benefit of continuing ovulation induction beyond six cycles becomes significantly smaller.
Letrozole Success Rate by Age
Letrozole is prescribed for ovulation induction, not for IVF. Success rates by age for ovulation induction are distinct from IVF outcomes and should not be compared directly. With that context, approximate live birth rate ranges by age bracket for PCOS patients on letrozole, referenced against CDC ART data for general context, are:
Under 35 shows the highest ovulatory response, with per-cycle live birth rates approaching 20 to 27%. From 35 to 37, response rates decline modestly, with LBR closer to 15 to 20% per cycle. From 38 to 40, the decline becomes more clinically significant; earlier escalation to IVF is often recommended at this stage. Over 40, ovulatory response to letrozole falls meaningfully, and a conversation about IVF with donor eggs typically becomes appropriate sooner. According to US national ART data from SART, age is the single strongest predictor of fertility treatment outcomes across all modalities.
What Women with PCOS Tell Us About Letrozole
Women who come to Avida after unsuccessful first letrozole cycles often arrive with the same question: “Is it normal that 2.5mg didn’t work for me?” The answer is yes. A significant proportion of PCOS patients require at least one dose adjustment before they see a meaningful ovulatory response. What matters most is that dose escalation happens systematically, under close ultrasound monitoring, and with enough cycles at each level to draw a reliable conclusion.
In our experience working with PCOS patients, women who didn’t ovulate at 2.5mg frequently respond once the dose is titrated to 5mg or 7.5mg. The process takes patience, but the escalation protocol exists precisely because the dose range is wide and the response is individual. We also find that women with insulin resistance who address that component alongside letrozole, through diet adjustments, metformin when appropriate, or both, tend to respond more consistently across dose levels.
What we don’t see is a ceiling effect at one dose that predicts failure at the next. Not responding at 2.5mg is not a signal that treatment won’t work. It’s a signal that your ovaries need a different input, and the dose escalation protocol is designed for exactly that situation.
Monitoring and Safety Considerations
When letrozole doses increase, monitoring becomes more important. Higher doses can stimulate multiple follicles, which needs careful tracking to manage the risk of multiple pregnancy. Your fertility team will follow your response using the methods in the table below:
Higher doses may increase the risk of multiple follicle development. Your specialist will adjust your protocol based on your individual response at each cycle. Monitoring is not optional at higher dose levels; it’s what allows the escalation to happen safely.
Combining Letrozole with Other Treatments
Letrozole alone is sometimes not enough, and combining it with complementary interventions can improve per-cycle results. The table below covers the most common combination approaches:
The trigger shot row is worth expanding on. Adding an hCG (human chorionic gonadotropin) trigger shot to letrozole improves timed intercourse precision and increases per-cycle pregnancy rates, particularly useful when natural LH surge detection is inconsistent. This is especially relevant for patients who ovulate at higher doses but have irregular or undetectable LH surges.
When to Consider Moving to IVF
After six unsuccessful letrozole cycles at the maximum tolerated dose, most clinical guidelines recommend reassessing toward IVF. ASRM clinical guidelines support this threshold, as the incremental benefit of continuing ovulation induction beyond six cycles becomes significantly smaller and assisted reproductive technologies become more cost-effective as a next step. The updated Cochrane systematic review on letrozole versus clomiphene for PCOS (Franik et al. 2022, PMID 36165742) provides additional supporting evidence for letrozole as the superior first-line agent and for the clinical rationale behind transitioning when it no longer achieves results.
Additional clinical triggers for moving to IVF earlier include age over 38, the presence of a male factor or tubal factor alongside PCOS, and multiple follicle development at maximum dose that makes monitoring unsafe.
For US patients, the “when to move to IVF” decision carries a financial dimension that competitors treating purely domestic patients can’t address. In the United States, a single IVF cycle costs $12,000 to $17,000 before medications, with total per-cycle costs often reaching $15,000 to $30,000. If you’ve completed six letrozole monitoring cycles at $500 to $1,500 each, the cumulative spend approaches $5,000 to $9,000 with no result. At Avida Fertility, IVF treatment in Mexico is available at 40 to 60% of US pricing (2026 market reference). Many US patients who transition from ovulation induction to IVF find that the Mexico cost structure makes this move financially viable at the four-cycle mark rather than six, without compromising clinical outcomes. If you are weighing this transition, you can review your treatment options and expected costs before deciding on your next step.
Care that starts by listening to you.
We know every story is different and that taking the first step takes courage. Our medical team takes the time to assess your overall health and walk you through your options step by step, in a safe space and with complete transparency.
Lifestyle Factors That Support Letrozole Success
Lifestyle changes don’t replace letrozole, but they can meaningfully improve how you respond to it, particularly for patients with insulin-resistant PCOS. Even a 5 to 10% reduction in body weight can improve ovulation rates in women with PCOS who are above a clinically meaningful BMI threshold.
These changes work best when implemented before or alongside your first letrozole cycle, not after several unsuccessful ones. If you have insulin resistance, your specialist may also recommend metformin as a complement to letrozole from the outset.
Side Effects of Letrozole at Higher Doses
Most side effects of letrozole are dose-dependent and temporary. They resolve when the medication cycle ends, though higher doses may produce more pronounced symptoms. Knowing what to expect makes the process easier to manage:
Side effects at 7.5mg and 10mg can be more pronounced than at 2.5mg, but most patients find them manageable within the five-day dosing window. Always communicate with your specialist about any side effects that feel severe or unusual, as they may prompt a protocol adjustment.
The Importance of Personalized PCOS Treatment
PCOS presents differently in every patient. Hormone profiles, insulin resistance levels, BMI, and treatment history all influence how you respond to letrozole and at what dose. There is no universal starting protocol that works for everyone with PCOS, which is why clinical evaluation before beginning treatment is essential.
At Avida Fertility, our reproductive endocrinologists, including Dr. Daniel Pascal Pontón (SEP Cédula 13928465), develop individualized PCOS treatment protocols based on each patient’s hormone profile, insulin sensitivity, BMI, and prior cycle history. No two protocols are identical. Treatment is built around your specific PCOS phenotype, not a generic template.
Our clinical team holds COFEPRIS licensing, Mexico’s equivalent of FDA-level healthcare regulation, and has extensive experience supporting international patients from the United States and Canada through letrozole protocols and, when the time comes, the transition to IVF. Avida Fertility holds COFEPRIS licensing, Mexico’s equivalent of FDA-level healthcare regulation — and our letrozole monitoring protocols follow internationally recognized ASRM and ESHRE clinical standards. US and Canadian patients can begin with a free virtual consultation before scheduling travel to Mexico City. Talk with our team to understand your options before you commit to anything.
Moving Forward with PCOS Treatment
PCOS is one of the most treatable causes of infertility. Letrozole is a highly effective first step, and dose escalation exists precisely because the treatment has a real response range across patients. If 2.5mg didn’t work, it doesn’t mean the protocol has failed. It means you’re at the beginning of a systematic process, not the end of one.
Many US patients start with a free virtual consultation to evaluate where they are in their letrozole protocol and whether a transition to IVF makes clinical and financial sense at this stage. Our English-speaking team at Avida Fertility walks you through your options before you travel. Our English-speaking international patient coordinator handles scheduling, monitoring arrangements, and travel planning from your first virtual appointment. We support LGBTQ+ patients, single parents by choice, and any family structure navigating PCOS treatment, whether that means continuing letrozole cycles, transitioning to IUI, or beginning IVF. Explore fertility treatments in Mexico to understand your full range of options.
Schedule Your Free Virtual Consultation
References
- Legro RS, Brzyski RG, Diamond MP, et al. Letrozole versus Clomiphene for Infertility in the Polycystic Ovary Syndrome. New England Journal of Medicine. 2014;371(2):119–129. https://pubmed.ncbi.nlm.nih.gov/25006718/
- Society for Assisted Reproductive Technology (SART). IVF Success Rates. https://www.sart.org/patients/a-patients-guide-to-assisted-reproductive-technology/general-information/success-rates/
- American Society for Reproductive Medicine (ASRM). Recommendations from the 2023 International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. https://integration.asrm.org/globalassets/_asrm/practice-guidance/practice-guidelines/pdf/recommendations_from_the_2023_int_evidence-based_guideline_on_pcos.pdf
- Teede HJ, Khomami MB, Global Name Change Consortium, et al. Polyendocrine Metabolic Ovarian Syndrome, the New Name for Polycystic Ovary Syndrome: A Multistep Global Consensus Process. The Lancet. 2026;407(10545):2329–2339. https://doi.org/10.1016/S0140-6736(26)00717-8
- Franik S, Le QK, Kremer JAM, Kiesel L, Farquhar C. Aromatase Inhibitors (Letrozole) for Ovulation Induction in Infertile Women with Polycystic Ovary Syndrome. Cochrane Database of Systematic Reviews. 2022;9:CD010287. https://pubmed.ncbi.nlm.nih.gov/36165742/
Frequently Asked Questions
How long should I try increased letrozole doses before considering other options?
Most fertility specialists recommend 3 to 4 cycles at each dose level before escalating further. If you haven’t achieved pregnancy after a total of six cycles across dose levels, the ASRM supports moving to IVF or IUI as a next step.
Can I take letrozole for more than 6 cycles?
Letrozole can be continued beyond six cycles in select cases, but most guidelines recommend reassessing at that mark. At Avida Fertility, we evaluate your full response history at six cycles and present IVF as a cost-effective alternative for many patients at that point, particularly for US patients where the cumulative monitoring cost may have already approached $5,000 to $9,000.
Will higher doses increase my chances of twins?
Higher letrozole doses may slightly increase the chance of multiple follicle development, but the risk remains relatively low at 3 to 5%, compared to 8 to 10% with Clomid. Regular monitoring is specifically designed to manage this risk, including triggering cycle cancellation if too many follicles develop.
What if I ovulate but don’t get pregnant?
Ovulation is necessary but not sufficient for conception. If you’re ovulating regularly on letrozole but not conceiving, your specialist may recommend additional diagnostic testing (including an assessment of sperm parameters and fallopian tube patency) or combining letrozole with intrauterine insemination (IUI) to increase per-cycle success.
What are the chances of getting pregnant on letrozole?
Three metrics together give the clearest picture: ovulation rate of 70 to 85%, per-cycle pregnancy rate of 15 to 27%, and cumulative rate across multiple cycles of 45 to 50%. Individual outcomes vary by age, severity of PCOS, insulin resistance status, and protocol adherence. These figures are population-level statistics, not individual predictions.
Does letrozole work for women without PCOS or unexplained infertility?
Letrozole can induce ovulation in women without PCOS, but the evidence is weaker than for PCOS specifically. The mechanism that makes letrozole particularly effective in PCOS, its suppression of the androgen-to-estrogen conversion pathway, does not apply in the same way to women with normal androgen levels. For unexplained infertility, per-cycle pregnancy rates with letrozole are comparable to Clomid, and gonadotropins may outperform both for some patients. If you’re considering letrozole without a PCOS diagnosis, a full fertility workup evaluating ovarian reserve, tubal patency, and sperm parameters is the essential first step.
.png)
.svg)
.svg)
.svg)
